Uprifosbuvir
Uprifosbuvir is an antiviral agent. Uprifosbuvir is a NS5b inhibitor developed for the research of chronic hepatitis C virus[1].
Product Specifications
CAS Number
[1496551-77-9]
Product Name Alternative
IDX21437; MK-3682
UNSPSC
12352005
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/uprifosbuvir.html
Purity
99.20
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
C[C@]([C@@](N(C=CC1=O)C(N1)=O)([H])O[C@@H]2CO[P@@](OC3=CC=CC=C3)(N[C@H](C)C(OC(C)C)=O)=O)([C@@H]2O)Cl
Molecular Formula
C22H29ClN3O9P
Molecular Weight
545.91
References & Citations
[1]Klapars A, et al. Efficient synthesis of antiviral agent uprifosbuvir enabled by new synthetic methods. Chem Sci. 2021;12 (26) :9031-9036.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
043115-HRP 200 µL
TOE1, NT (TOE1, Target of EGR1 protein 1) (Azide free) (HRP) discontinued
Ask
View Details